Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma
Cancer Institute (WIA) · Guangdong Academy of Medical Sciences · +4 more institutions
Abstract
Backgrounds Immunotherapy is less effective in patients with epidermal growth factor receptor (EGFR) mutant non-small-cell lung cancer (NSCLC). Lower programmed cell death-ligand 1 (PD-L1) expression and tumor mutation burden (TMB) are reported to be the underlying mechanism. Being another important factor to affect the efficacy of immunotherapy, tumor microenvironment (TME) characteristics of this subgroup of NSCLC are not comprehensively understood up to date. Hence, we initiated this study to describe the specific TME of EGFR-mutant lung adenocarcinoma (LUAD) from cellular compositional and functional perspectives to better understand the immune landscape of this most common subtype of NSCLC. Methods We…
Citation impact
- FWCI
- 23.82
- Percentile
- 100%
- References
- 52
Authors
13- LYLei YangCorresponding
Cancer Institute (WIA), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University
- YHYun-Ting He
Cancer Institute (WIA), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
- SDSong Dong
Cancer Institute (WIA), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
- XWXue‐Wu Wei
Cancer Institute (WIA), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
- ZCZhihong Chen
Cancer Institute (WIA), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
Topics & keywords
- Immunotherapy
- Cancer research
- Epidermal growth factor receptor
- Tumor microenvironment
- CD8
- Adenocarcinoma
- Immune system
- Lung cancer
- Good health and well-being